Press Release – GDMC Raises US$21M in Series A Funding
Singapore Advanced Therapy Drug Manufacturer GDMC Secures US$21 Million Growth Capital Funding to Expand Global…
Continue ReadingSingapore Advanced Therapy Drug Manufacturer GDMC Secures US$21 Million Growth Capital Funding to Expand Global…
Continue ReadingReducing costs of gene therapies: Applying lean manufacturing principles for accessible genetic medicines.
Continue ReadingDeveloping advanced analytical methods for high-complexity therapeutic modalities.
Continue ReadingAdvancing targeted delivery of LNPs for safer and more effective therapies and vaccines.
Continue ReadingPassive and local administration for LNPs: Optimizing targeting and distribution.
Continue Reading